DAB2IP and posterior cortical atrophy: Here, we found that DAB2IP-deficient PCa cells exhibit a higher sensitivity toward Mps1 inhibitor (AZ3146) at a lower dosage than DAB2IP-proficient PCa cells do (Fig. 4A).